mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

The Role of Panton-Valentine Leukocidin in Staphylococcus aureus Musculoskeletal Infections in Children

Ritz N et al. – This review summarizes the current evidence on the influence of Panton–Valentine leukocidin (PVL) on musculoskeletal infections caused by S. aureus in children and highlights areas of uncertainty relating to management.

  • Infections caused by Panton-Valentine leukocidin (PVL)–producing strains of Staphylococcus aureus have been reported with increasing frequency.
  • However, the role of PVL in the pathogenesis of invasive staphylococcal infection is controversial.
  • It is interesting to note that the role played by PVL may depend on the site of infection; although an association between PVL and severity has been reported in lung and bone infection, this is not the case for skin and soft tissue infection.
  • A number of recent reports describe severe complications associated with PVL-producing strains in musculoskeletal infections.

[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close